Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Zealand Pharma - Filing #5889383

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	Sensitivity	—	—	—	—	—	—	—	—	—	—	—
Reserve of exchange differences on translation	—	—	—	22,388,000 DKK	—	—	—	—	22,704,000 DKK	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	—	977,896,000 DKK	—	—	—	—	200,205,000 DKK	—	—	—
Current assets	—	—	—	8,527,704,000 DKK	—	—	—	—	1,779,788,000 DKK	—	—	—
Non-current liabilities	—	—	—	485,385,000 DKK	—	—	—	—	102,575,000 DKK	—	—	—
Current liabilities	—	—	—	403,473,000 DKK	—	—	—	—	284,579,000 DKK	—	—	—
Revenue	62,691,000 DKK	—	—	—	—	—	—	342,788,000 DKK	—	—	—	—
Profit (loss)	1,078,828,000 DKK	- DKK	- DKK	—	- DKK	1,078,828,000 DKK	- DKK	703,739,000 DKK	—	- DKK	703,739,000 DKK	- DKK
Comprehensive income	1,079,144,000 DKK	- DKK	- DKK	—	316,000 DKK	1,078,828,000 DKK	- DKK	695,652,000 DKK	—	- DKK	703,739,000 DKK	8,087,000 DKK